Cerus EBITDA 2010-2025 | CERS
Cerus ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Cerus Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-12 |
| 2023 | $-27 |
| 2022 | $-31 |
| 2021 | $-46 |
| 2020 | $-55 |
| 2019 | $-64 |
| 2018 | $-54 |
| 2017 | $-56 |
| 2016 | $-60 |
| 2015 | $-59 |
| 2014 | $-43 |
| 2013 | $-28 |
| 2012 | $-17 |
| 2011 | $-15 |
| 2010 | $-15 |
| 2009 | $-23 |
| Cerus Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-6 |
| 2024-12-31 | $-1 |
| 2024-09-30 | $-1 |
| 2024-06-30 | $-3 |
| 2024-03-31 | $-7 |
| 2023-12-31 | $2 |
| 2023-09-30 | $-5 |
| 2023-06-30 | $-11 |
| 2023-03-31 | $-14 |
| 2022-12-31 | $-9 |
| 2022-09-30 | $-7 |
| 2022-06-30 | $-6 |
| 2022-03-31 | $-9 |
| 2021-12-31 | $-6 |
| 2021-09-30 | $-10 |
| 2021-06-30 | $-14 |
| 2021-03-31 | $-16 |
| 2020-12-31 | $-14 |
| 2020-09-30 | $-13 |
| 2020-06-30 | $-14 |
| 2020-03-31 | $-15 |
| 2019-12-31 | $-16 |
| 2019-09-30 | $-16 |
| 2019-06-30 | $-16 |
| 2019-03-31 | $-16 |
| 2018-12-31 | $-15 |
| 2018-09-30 | $-13 |
| 2018-06-30 | $-12 |
| 2018-03-31 | $-13 |
| 2017-12-31 | $-10 |
| 2017-09-30 | $-12 |
| 2017-06-30 | $-16 |
| 2017-03-31 | $-18 |
| 2016-12-31 | $-15 |
| 2016-09-30 | $-14 |
| 2016-06-30 | $-16 |
| 2016-03-31 | $-15 |
| 2015-12-31 | $-15 |
| 2015-09-30 | $-16 |
| 2015-06-30 | $-15 |
| 2015-03-31 | $-14 |
| 2014-12-31 | $-13 |
| 2014-09-30 | $-11 |
| 2014-06-30 | $-11 |
| 2014-03-31 | $-9 |
| 2013-12-31 | $-7 |
| 2013-09-30 | $-8 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $-5 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $-4 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-4 |
| 2011-12-31 | $-3 |
| 2011-09-30 | $-3 |
| 2011-06-30 | $-5 |
| 2011-03-31 | $-4 |
| 2010-12-31 | $-4 |
| 2010-09-30 | $-3 |
| 2010-06-30 | $-3 |
| 2010-03-31 | $-4 |
| 2009-12-31 | $-5 |
| 2009-09-30 | $-6 |
| 2009-06-30 | $-5 |
| 2009-03-31 | $-7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.255B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $225.215B | 26.41 |
| Boston Scientific (BSX) | United States | $151.880B | 36.22 |
| Stryker (SYK) | United States | $144.875B | 29.49 |
| EssilorLuxottica (ESLOY) | France | $142.491B | 0.00 |
| Medtronic (MDT) | Ireland | $119.092B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.952B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.526B | 24.85 |
| ResMed (RMD) | United States | $42.208B | 30.19 |
| GE HealthCare Technologies (GEHC) | United States | $34.393B | 16.17 |
| Agilent Technologies (A) | United States | $34.170B | 22.28 |
| Terumo (TRUMY) | Japan | $27.923B | 33.09 |
| Koninklijke Philips (PHG) | Netherlands | $26.278B | 17.38 |
| Insulet (PODD) | United States | $21.729B | 72.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.447B | 13.02 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.109B | 0.00 |
| Baxter (BAX) | United States | $12.383B | 9.57 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.771B | 28.55 |
| Lantheus Holdings (LNTH) | United States | $3.657B | 9.89 |
| Envista Holdings (NVST) | United States | $3.583B | 25.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.269B | 14.50 |
| Perrigo (PRGO) | Ireland | $3.255B | 8.13 |
| ICU Medical (ICUI) | United States | $2.817B | 19.18 |
| Haemonetics (HAE) | United States | $2.596B | 11.59 |
| LeMaitre Vascular (LMAT) | United States | $2.154B | 46.19 |
| Curaleaf Holdings (CURLF) | Canada | $2.065B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.899B | 81.54 |
| QuidelOrtho (QDEL) | United States | $1.839B | 11.57 |
| AtriCure (ATRC) | United States | $1.824B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.376B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.316B | 18.75 |
| Phibro Animal Health (PAHC) | United States | $1.255B | 16.04 |
| BioLife Solutions (BLFS) | United States | $1.230B | 2568.00 |
| Neogen (NEOG) | United States | $1.203B | 19.10 |
| Acuren (TIC) | United States | $1.169B | 0.00 |
| Valneva SE (VALN) | France | $0.950B | 0.00 |
| InMode (INMD) | Israel | $0.926B | 8.57 |
| Kestra Medical Technologies (KMTS) | United States | $0.816B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.700B | 0.00 |
| SNDL (SNDL) | Canada | $0.562B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.547B | 0.00 |
| Surmodics (SRDX) | United States | $0.543B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.532B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| VAREX IMAGING (VREX) | United States | $0.444B | 15.27 |
| CeriBell (CBLL) | United States | $0.437B | 0.00 |
| Evolus (EOLS) | United States | $0.421B | 0.00 |
| Owens & Minor (OMI) | United States | $0.412B | 3.65 |
| Capricor Therapeutics (CAPR) | United States | $0.379B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.342B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.312B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.284B | 21.56 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.272B | 0.00 |
| Omeros (OMER) | United States | $0.264B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.262B | 0.00 |
| Brainsway (BWAY) | Israel | $0.240B | 48.85 |
| Quanterix (QTRX) | United States | $0.223B | 0.00 |
| Organigram Global (OGI) | Canada | $0.214B | 0.00 |
| Exagen (XGN) | United States | $0.213B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.200B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.88 |
| Biote (BTMD) | United States | $0.168B | 5.03 |
| FitLife Brands (FTLF) | United States | $0.152B | 18.75 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| MacroGenics (MGNX) | United States | $0.105B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.19 |
| Apyx Medical (APYX) | United States | $0.089B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Safety Shot (SHOT) | United States | $0.076B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| Veru (VERU) | United States | $0.050B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.33 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.39 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |